In the preceding three months, 12 analysts have released ratings for DexCom (NASDAQ:DXCM), presenting a wide array of ...

The 12-month price targets, analyzed by analysts, offer insights with an average target of $75.25, a high estimate of $104.00 ...

Throughout the last three months, 6 analysts have evaluated Qorvo (NASDAQ:QRVO), offering a diverse set of opinions from bullish to bearish. Summarizing their recent assessments, the table below ...

Ratings for NovoCure (NASDAQ:NVCR) were provided by 4 analysts in the past three months, showcasing a mix of bullish and bearish perspectives. The table below offers a condensed view of their recent ...

Compare KnockoutStocks vs MarketBeat for AI tools, stock analysis, screeners, picks, and portfolio tracking. Find the best ...